Suppr超能文献

中胚层基质细胞,中胚层前体细胞,可分化为间充质细胞和内皮细胞。

The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells.

机构信息

Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA.

Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, 53707, USA.

出版信息

Cell Mol Life Sci. 2018 Oct;75(19):3507-3520. doi: 10.1007/s00018-018-2871-3. Epub 2018 Jul 10.

Abstract

Mesenchymoangioblast (MB) is the earliest precursor for endothelial and mesenchymal cells originating from APLNRPDGFRαKDR mesoderm in human pluripotent stem cell cultures. MBs are identified based on their capacity to form FGF2-dependent compact spheroid colonies in a serum-free semisolid medium. MBs colonies are composed of PDGFRβCD271EMCNDLK1CD73 primitive mesenchymal cells which are generated through endothelial/angioblastic intermediates (cores) formed during first 3-4 days of clonogenic cultures. MB-derived primitive mesenchymal cells have potential to differentiate into mesenchymal stromal/stem cells (MSCs), pericytes, and smooth muscle cells. In this review, we summarize the specification and developmental potential of MBs, emphasize features that distinguish MBs from other mesenchymal progenitors described in the literature and discuss the value of these findings for identifying molecular pathways leading to MSC and vasculogenic cell specification, and developing cellular therapies using MB-derived progeny.

摘要

间充质-血管母细胞(MB)是源自人多能干细胞培养物中 APLNRPDGFRαKDR 中胚层的内皮和间充质细胞的最早前体细胞。MB 根据其在无血清半固体培养基中形成 FGF2 依赖性紧密球体集落的能力来鉴定。MB 集落由 PDGFRβCD271EMCNDLK1CD73 原始间充质细胞组成,这些细胞是通过在克隆培养的头 3-4 天形成的内皮/成血管细胞中间产物(核心)产生的。MB 衍生的原始间充质细胞具有分化为间充质基质/干细胞(MSCs)、周细胞和平滑肌细胞的潜力。在这篇综述中,我们总结了 MB 的特征和发育潜力,强调了将 MB 与文献中描述的其他间充质祖细胞区分开来的特征,并讨论了这些发现对于鉴定导致 MSC 和血管生成细胞特化的分子途径以及使用 MB 衍生后代开发细胞疗法的价值。

相似文献

1
The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells.
Cell Mol Life Sci. 2018 Oct;75(19):3507-3520. doi: 10.1007/s00018-018-2871-3. Epub 2018 Jul 10.
2
A mesoderm-derived precursor for mesenchymal stem and endothelial cells.
Cell Stem Cell. 2010 Dec 3;7(6):718-29. doi: 10.1016/j.stem.2010.11.011.
3
Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts.
Cell Rep. 2017 May 30;19(9):1902-1916. doi: 10.1016/j.celrep.2017.05.019.
4
Endothelial origin of mesenchymal stem cells.
Cell Cycle. 2011 May 1;10(9):1370-3. doi: 10.4161/cc.10.9.15345.
7
Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells.
Stem Cell Reports. 2018 Feb 13;10(2):436-446. doi: 10.1016/j.stemcr.2017.12.005. Epub 2018 Jan 4.
8
Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells.
Cell Cycle. 2013 Mar 1;12(5):720-7. doi: 10.4161/cc.23823. Epub 2013 Feb 6.
9
Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.
Stem Cells Transl Med. 2012 Feb;1(2):83-95. doi: 10.5966/sctm.2011-0022. Epub 2012 Feb 7.

引用本文的文献

1
models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade.
Front Cell Dev Biol. 2025 Jan 3;12:1463807. doi: 10.3389/fcell.2024.1463807. eCollection 2024.
4
Mesodermal Derivatives of Pluripotent Stem Cells Route to Scarless Healing.
Int J Mol Sci. 2023 Jul 26;24(15):11945. doi: 10.3390/ijms241511945.
6
Lateral Mesoderm-Derived Mesenchymal Stem Cells With Robust Osteochondrogenic Potential and Hematopoiesis-Supporting Ability.
Front Mol Biosci. 2022 Apr 28;9:767536. doi: 10.3389/fmolb.2022.767536. eCollection 2022.
7
A microRNA Cluster-Lefty Pathway is Required for Cellulose Synthesis During Ascidian Larval Metamorphosis.
Front Cell Dev Biol. 2022 Mar 15;10:835906. doi: 10.3389/fcell.2022.835906. eCollection 2022.
9
Stem Cell-Based Therapies: What Interventional Radiologists Need to Know.
Semin Intervent Radiol. 2021 Nov 24;38(5):523-534. doi: 10.1055/s-0041-1736657. eCollection 2021 Dec.

本文引用的文献

1
Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
Mol Ther. 2018 Apr 4;26(4):1093-1108. doi: 10.1016/j.ymthe.2018.01.021. Epub 2018 Feb 2.
2
Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells.
Stem Cell Reports. 2018 Feb 13;10(2):436-446. doi: 10.1016/j.stemcr.2017.12.005. Epub 2018 Jan 4.
3
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.
Sci Transl Med. 2017 Nov 15;9(416). doi: 10.1126/scitranslmed.aam7828.
4
Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2026-2037. doi: 10.1161/ATVBAHA.117.309196. Epub 2017 Aug 31.
5
Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.
Stem Cells Transl Med. 2017 Oct;6(10):1859-1867. doi: 10.1002/sctm.16-0484. Epub 2017 Aug 24.
7
Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts.
Cell Rep. 2017 May 30;19(9):1902-1916. doi: 10.1016/j.celrep.2017.05.019.
8
Development of Mural Cells: From In Vivo Understanding to In Vitro Recapitulation.
Stem Cells Dev. 2017 Jul 15;26(14):1020-1041. doi: 10.1089/scd.2017.0020. Epub 2017 Jun 20.
10
A systematic review: differentiation of stem cells into functional pericytes.
FASEB J. 2017 May;31(5):1775-1786. doi: 10.1096/fj.201600951RRR. Epub 2017 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验